News

Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells—known as ...
Rabies is notoriously difficult to treat once symptoms begin, and that challenge starts at the molecular level. Unlike many ...
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...
Researchers at the Lewis Katz School of Medicine at Temple University have identified a new strategy that may help repair damaged heart tissue by reactivating an important developmental gene.
University of Geneva researchers led a collaboration for testing different size-exclusion chromatography columns to compare ...
A group of Australian scientists has uncovered a new way to fight some of the toughest cancers by targeting an overlooked ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...
Adrian R. Krainer has been awarded the 2025 Heinrich Wieland Prize for his pioneering RNA research that led to the ...
Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...
A group of University of Ottawa researchers have already shown how scientists can harness gene therapies to deliver ...